ARTICLE | Clinical News
Neptune Technologies preclinical data
September 27, 2010 7:00 AM UTC
In healthy rats, human equivalent dosing with 1 g/day of Acasti Pharma Inc.'s CaPre long-chain omega-3 phospholipids for 2 months increased total levels of the cardioprotective omega-3 fatty acids eic...